MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)
source: myfinsight.com
Download
Download image
Product
$73,563K
(22.66%↑ Y/Y)
License Collaboration
And Royalty Revenue
$4,142K
(66.08%↑ Y/Y)
Total revenue
$77,705K
(24.40%↑ Y/Y)
Income from operations
$41,422K
(89.60%↑ Y/Y)
Interest income
$3,515K
(-1.51%↓ Y/Y)
Total operating
expenses
$36,283K
(-10.67%↓ Y/Y)
Net income before
income taxes
$43,925K
(80.40%↑ Y/Y)
Interest expense
$1,012K
(-5.15%↓ Y/Y)
Selling, general and
administrative
$22,029K
(8.31%↑ Y/Y)
Research and development
$7,470K
(30.07%↑ Y/Y)
Cost of revenue
$6,505K
(-24.13%↓ Y/Y)
Other expense, net
-$279K
(93.70%↑ Y/Y)
Net income
$34,355K
(47.17%↑ Y/Y)
Income tax expense
$9,570K
(852.24%↑ Y/Y)
Comprehensive income
$34,074K
(47.09%↑ Y/Y)
Unrealized loss on
available-for-sale securities
-$281K
(-57.87%↓ Y/Y)
Back